Join
Live feed
·
INSIDERFilingvia Quantisnow
Viridian Therapeutics Inc. logo

President and CEO Mahoney Stephen F. converted options into 18,357 shares and covered exercise/tax liability with 7,627 shares, increasing direct ownership by 48% to 33,130 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRDN· Viridian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRDN (Viridian Therapeutics Inc.) and more on Quantisnow.